Directory snapshot
Chapel Hill biotech startups by stage
Of 5 startups with a recorded funding stage, 5 are at grant, pre-seed, or seed.
- tracked startups
- 13
- hiring now
- 0
- grant through seed
- 5
All 13 biotech startups headquartered in Chapel Hill
BioKier
Biotech
Develops treatments for diabetes and cardiometabolic disease based on the effects of gastric bypass surgery.
DelAQUA Pharmaceuticals
Biotech
Develops a polymer micelle platform that makes poorly soluble drugs more soluble, stable, and bioavailable.
Enfuego Therapeutics
Biotech
Develops peptide-oligonucleotide conjugate siRNAs for solid tumors.
GeneVentiv Therapeutics
Biotech · Pre-seed
UNC Chapel Hill Gene Therapy Center spinout developing GENV HEM, a universal gene therapy for all types of hemophilia (including patients with inhibitors to clotting factors); pipeline expanded to include a Pompe disease program in 2025.
InoKare Therapeutics
Biotech · Seed
Small-molecule inhibitors targeting obesity and metabolic disorders
iOrganBio
Biotech · Seed
AI-powered cell manufacturing platform for human cell production
M34
Biotech
Develops gene therapies that cross the blood-brain barrier for neurological disease, and nonviral gene vectors for hemophilia A.
Persistence Therapeutics
Biotech · Seed
Implantable synthetic lymph node for CAR-T cell generation
Quanticision Diagnostics
Biotech
Develops quantitative protein biomarker assays and companion diagnostics for cancer therapy using its Quantitative Dot Blot platform.
Sollus Therapeutics, Inc.
Biotech
Develops immune cell therapies for oncology and autoimmunity, including a screening platform for chimeric antigen receptor optimization.
TransChromix LLC
Biotech · Grant
Chapel Hill therapeutics company developing brain-penetrant small molecules for Alzheimer's disease and other conditions using chromatin-activity-based chemoproteomics.
Triangle Biotechnology
Biotech
Develops ultrasound-activated reagents and microplate sonication tools that speed DNA and chromatin sample prep for sequencing and epigenetic assays.
Tripill Biotechnology Corp.
Biotech
Develops targeted radionuclide therapeutics, including a radiolabeled PSMA agent designed for low salivary gland uptake and astatine-211 agents for melanoma.
Browsing is free. Opening a company shows the basics; founders, funding, and signals are in the full profile behind a free account. Open roles across Triangle companies are tracked on the jobs page. Numbers refresh from the database.